Skip to main content

Question 3

In human biomarker research, what is the evidence that airborne exposures during deployment: (3a) Result in measurable biomarker differences between deployed versus non-deployed military? (3b) Result in changes in biomarkers implicated in pro-inflammatory and pro-fibrotic pathways (e.g., change in expression of cytokines or miRNAs associated with disease risk)?